| A facile approach to enhance antigen response for personalized cancer vaccination AW Li, MC Sobral, S Badrinath, Y Choi, A Graveline, AG Stafford, ... Nature materials 17 (6), 528-534, 2018 | 222 | 2018 |
| Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors H Wang, AJ Najibi, MC Sobral, BR Seo, JY Lee, D Wu, AW Li, ... Nature communications 11 (1), 1-14, 2020 | 41 | 2020 |
| Metabolic labeling and targeted modulation of dendritic cells H Wang, MC Sobral, DKY Zhang, AN Cartwright, AW Li, MO Dellacherie, ... Nature materials 19 (11), 1244-1252, 2020 | 39 | 2020 |
| Strategies to enhance the distribution of nanotherapeutics in the brain C Zhang, P Mastorakos, M Sobral, S Berry, E Song, E Nance, ... Journal of Controlled Release 267, 232-239, 2017 | 19 | 2017 |
| Clickable, acid labile immunosuppressive prodrugs for in vivo targeting H Wang, MC Sobral, T Snyder, Y Brudno, VS Gorantla, DJ Mooney Biomaterials science 8 (1), 266-277, 2020 | 11 | 2020 |
| Establishing a Quantitative Endpoint for Transarterial Embolization From Real-Time Pressure Measurements PC Gowda, VX Chen, MC Sobral, TL Bobrow, TG Romer, AK Palepu, ... Journal of Medical Devices 15 (2), 2021 | | 2021 |
| Abstract B045: Antigen-free cancer vaccine to treat poorly immunogenic tumors MC Sobral, H Wang, AJ Najibi, A Li, CS Verbeke, DJ Mooney Cancer Immunology Research 7 (2 Supplement), B045-B045, 2019 | | 2019 |
| Abstract B119: DC-recruiting biomaterial vaccine to enhance antitumor immunity AW Li, MO Dellacherie, M Sobral, OO Ali, J Kim, DJ Mooney Cancer Immunology Research 7 (2 Supplement), B119-B119, 2019 | | 2019 |
David MooneyHarvard, MIT, MichiganEmail yang diverifikasi di seas.harvard.edu
